Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
Beltran H, Romanel A, Conteduca V, Casiraghi N, Sigouros M, Franceschini GM, Orlando F, Fedrizzi T, Ku SY, Dann E, Alonso A, Mosquera JM, Sboner A, Xiang J, Elemento O, Nanus DM, Tagawa ST, Benelli M, Demichelis F.
Beltran H, et al. Among authors: demichelis f.
J Clin Invest. 2020 Apr 1;130(4):1653-1668. doi: 10.1172/JCI131041.
J Clin Invest. 2020.
PMID: 32091413
Free PMC article.
Clinical Trial.